Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (211-220 of 315) with videos related to

Pageof 32
Sort By:
Clinical Colorectal Cancer|July 16, 2020
FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall SurvivalAlexandre A Jácome, Bryan Kee, David Fogelman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case SeriesRahel Demisse, Neha Damle, Edward Kim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2007
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survivalYun Shin Chun, Jean-Nicolas Vauthey, Dario Ribero, et al.
Annals of Surgery|August 3, 2017
Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver MetastasesYun Shin Chun, Guillaume Passot, Suguru Yamashita, et al.
Cancers|January 25, 2025
The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal CancerDeepak Bhamidipati, Jay R Johnson, Kangyu Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancerChristopher H Crane, Cathy Eng, Barry W Feig, et al.
JCO Oncology Practice|February 3, 2021
Moving Beyond the Momentum: Innovative Approaches to Clinical Trial ImplementationCathy Eng, Emerson Y Chen, Jane Rogers, et al.
Oncotarget|April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinomaKrittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.
The Lancet. Oncology|April 21, 2019
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trialCathy Eng, Tae Won Kim, Johanna Bendell, et al.
Annals of Surgical Oncology|July 12, 2017
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient SelectionTravis E Grotz, Michael J Overman, Cathy Eng, et al.
Pageof 32

Showing results (211-220 of 315) with videos related to

Sort By:
Pageof 32
Clinical Colorectal Cancer|July 16, 2020
FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall SurvivalAlexandre A Jácome, Bryan Kee, David Fogelman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case SeriesRahel Demisse, Neha Damle, Edward Kim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2007
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survivalYun Shin Chun, Jean-Nicolas Vauthey, Dario Ribero, et al.
Annals of Surgery|August 3, 2017
Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver MetastasesYun Shin Chun, Guillaume Passot, Suguru Yamashita, et al.
Cancers|January 25, 2025
The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal CancerDeepak Bhamidipati, Jay R Johnson, Kangyu Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancerChristopher H Crane, Cathy Eng, Barry W Feig, et al.
JCO Oncology Practice|February 3, 2021
Moving Beyond the Momentum: Innovative Approaches to Clinical Trial ImplementationCathy Eng, Emerson Y Chen, Jane Rogers, et al.
Oncotarget|April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinomaKrittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.
The Lancet. Oncology|April 21, 2019
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trialCathy Eng, Tae Won Kim, Johanna Bendell, et al.
Annals of Surgical Oncology|July 12, 2017
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient SelectionTravis E Grotz, Michael J Overman, Cathy Eng, et al.
Pageof 32